scispace - formally typeset
M

Mahaboobkhan Rasool

Researcher at VIT University

Publications -  95
Citations -  2892

Mahaboobkhan Rasool is an academic researcher from VIT University. The author has contributed to research in topics: Arthritis & RANKL. The author has an hindex of 28, co-authored 88 publications receiving 2297 citations. Previous affiliations of Mahaboobkhan Rasool include University of Madras & Management and Science University.

Papers
More filters
Journal ArticleDOI

miR-506-3p alleviates uncontrolled osteoclastogenesis via repression of RANKL/NFATc1 signaling pathway.

TL;DR: It is predicted that miR‐506‐3p can be used as a molecular intervention for RANKL/NFATc1 mediated osteoclastogenesis.
Journal ArticleDOI

Trikatu, a herbal compound that suppresses monosodium urate crystal-induced inflammation in rats, an experimental model for acute gouty arthritis

TL;DR: It is indicated that trikatu exert a potent anti‐inflammatory effect against monosodium urate crystal‐induced inflammation in rats in association with analgesic and anti‐pyretic effects in the absence of gastrointestinal damage.
Journal ArticleDOI

Berberine coated mannosylated liposomes curtail RANKL stimulated osteoclastogenesis through the modulation of GSK3β pathway via upregulating miR-23a

TL;DR: It is endorsed that preferential internalization of ML-BBR by BMMs effectively modulated the RANKL/p-GSK3β pathway and curtailed the osteoclast-mediated bone erosion possibly through post-transcriptional gene silencing via miR-23a.

In vivo and in vitro immunomodulatory effects of indian ayurvedic herbal formulation triphala on experimental induced inflammation

TL;DR: Observations suggest that Triphala caused immunosuppression in experimental induced inflammation, indicating that they may provide an alternative approach to the treatment of inflammatory and autoimmune diseases.
Journal ArticleDOI

Protective effect of administration of Withania somifera against bromobenzene induced nephrotoxicity and mitochondrial oxidative stress in rats.

TL;DR: The oral administration of W. somnifera offered a significant dose-dependent protection to the biochemical alterations as observed in the bromobenzene alone treated rats, which was also evidenced by histopathology.